OCX Dividend History & Description — Oncocyte Corp
Oncocyte is a precision diagnostics company focused on developing and commercializing proprietary tests in three areas: DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, VitaGraft is a blood-based solid organ transplantation monitoring test and DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. When considering the Oncocyte Corp stock dividend history, we have taken known splits into account, such that the OCX dividend history is presented on a split-adjusted ("apples to apples") basis. Oncocyte Corp dividend history is presented both in graphical/chart form, and as a OCX dividend history data table along the right-hand column.
OCX — Key Stats (updated Friday, April 26, 10:21 AM)
The OCX dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable OCX historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the OCX dividend history record. Also see the OCX stock dividend history data table along the right-hand column below.